New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Scientists from the Chinese Academy of Sciences (CAS) have made a groundbreaking discovery about aging, raising the question: ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...